Tackling cancer with real-world data and human-centred AI.
About OPTIMAWhat we are
Turning evidence
into care
A pan-European platform connecting data, guidelines and tools to improve cancer care.
OPTIMA is a continuously evolving ecosystem dedicated to the digital transformation of oncology. We bridge the gap between clinical research and daily practice to ensure that data-driven insights reach those who need them most: the patients. By connecting privacy-preserving data access with validated clinical knowledge, we create usable solutions for the future of cancer care.
For Healthcare Professionals
Decision support and access to up-to-date evidence to enhance patient outcomes in everyday clinical practice.
Learn more
Our Ambition
Improving the life of
every cancer patient.
Because every discovery should reach the patient who needs it.
Cancer care is complex, but data-driven insights bring clarity. We use advanced technology to provide personalized treatment recommendations—placing the human experience at the heart of every innovation.
Our Ambition
Federated Data at Scale
Access Europe's largest high-quality oncology datasets. Through our federated approach, data stays local and secure while you gain the insights you need.
Learn moreAI-Driven Clinical Intelligence
Leverage validated AI tools and the Research Question Genie to transform complex real-world evidence into actionable clinical decision support.
Learn more
One Access, All Tools
Stop switching between accounts. Our integrated platform provides a single entry point to Atlas, JupyterHub, and all OPTIMA-proprietary tools in one seamless workflow.
Learn morePerspectives on OPTIMA
The bridge between research and patient care.
Conchi Biurrun Spanish Breast Cancer Association
Conchi Biurrun, member of the Patient & Public Advisory Board (PPAB), shares how data-driven medicine impacted her journey. Discover how patients and researchers collaborate to shape the future of cancer care.
Read the full storyWant to reach out directly?
Our team is available to answer your questions about the OPTIMA project, platform access, and collaboration opportunities.
